Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App




LGC Clinical Diagnostics and AccuGenomics Collaborate on Enhancing Cancer Testing Accuracy

By LabMedica International staff writers
Posted on 11 Oct 2024

LGC (London, UK), a global leader in clinical diagnostics and genomics, and AccuGenomics (Wilmington, NC, USA), a pioneer in molecular diagnostic development, have entered into a new strategic partnership to combine LGC’s expertise in quality control solutions with AccuGenomics’ advanced NGS monitoring technologies, driving innovation in clinical diagnostic tools. More...

The companies will focus on developing highly accurate and reliable molecular diagnostics and quality control materials, fulfilling the vital needs of precision medicine and improving patient management. Through this collaboration, LGC and AccuGenomics intend to deliver enhanced solutions for cancer NGS testing quality control. LGC’s extensive clinical genomics reference material expertise, combined with AccuGenomics’ proprietary technology, will allow laboratories across the world to integrate third party controls into their procedures, ensuring more reliable, actionable patient results from NGS-based assays. Additionally, the companies will also develop custom reference materials for NGS assay validation, supporting the evolving landscape of precision diagnostics. LGC and AccuGenomics expect this collaboration to speed up the adoption of NGS technologies in clinical laboratories across the world.

“We are delighted to partner with AccuGenomics to further our mission of providing laboratories with cutting-edge quality control solutions,” said Bharathi Anekella, Executive Vice President of LGC. “This collaboration aligns perfectly with our vision of advancing global diagnostics and supporting healthcare providers with the tools they need to deliver better patient outcomes.”

“This partnership with LGC will expand the reach of our proprietary technologies and enable more laboratories to improve the reliability of their patient testing by NGS,” added Nick Lazaridis, President of AccuGenomics. “LGC is well aligned across the diagnostic, therapeutic and pharmaceutical sectors as a strategic distribution partner. Our focus is on improving the accuracy and sensitivity of challenging NGS applications like liquid biopsy detection for MRD; this partnership with LGC will accelerate the adoption of Accukit ctDNA MRD IS, and Accukit Myeloid DNA IS. Together, we can contribute to the development of more precise life-saving diagnostic tools that support personalized medicine, leading to more accurate clinical NGS tests.”

Related Links:
LGC 
AccuGenomics


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Gold Member
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.